Hormonal profiles after the menopause.
Journal: 1976/December - British Medical Journal
ISSN: 0007-1447
PUBMED: 974609
Abstract:
The endocrinological changes of the climacteric have been defined by studying the concentrations of follicle-stimulating hormone (FSH), luteinising hormone (LH), androstenedione, testosterone, oestrone, and oestradiol in 60 normal postmenopausal women of different menopausal ages. The women were studied in six groups, according to the number of years since their menopause. One year after the menopause androstenedione, oestrone, and oestradiol concentrations were reduced to about 20% of the values recorded during the early proliferative phase of the menstrual cycle. At the same time the mean concentration of FSH had risen by a factor of 13-4 and that of LH by a factor of 3-0. Concentrations of both gonadotrophins reached a peak of 18-4 and 3-4 times the proliferative phase value respectively after two to three years, and then gradually declined in the next three decades to values that were 40-50% of these maximal levels. Testosterone concentrations remained mostly in the normal range for premenopausal women but were depressed to 60% of these levels two to five years after the menopause, and the mean androstenedione levels showed a significant increase in the same group of women. The concentrations of both oestrone and oestradiol remained consistently low for 10 years after the menopause, but oestradiol concentrations inexplicably increased in the last two decades, with levels at the lower end of normal range for reproductive women in six patients.
Relations:
Content
Citations
(33)
References
(20)
Clinical trials
(1)
Drugs
(5)
Chemicals
(3)
Organisms
(1)
Processes
(3)
Anatomy
(1)
Similar articles
Articles by the same authors
Discussion board
Br Med J 2(6039): 784-787

Hormonal profiles after the menopause.

Abstract

The endocrinological changes of the climacteric have been defined by studying the concentrations of follicle-stimulating hormone (FSH), luteinising hormone (LH), androstenedione, testosterone, oestrone, and oestradiol in 60 normal postmenopausal women of different menopausal ages. The women were studied in six groups, according to the number of years since their menopause. One year after the menopause androstenedione, oestrone, and oestradiol concentrations were reduced to about 20% of the values recorded during the early proliferative phase of the menstrual cycle. At the same time the mean concentration of FSH had risen by a factor of 13-4 and that of LH by a factor of 3-0. Concentrations of both gonadotrophins reached a peak of 18-4 and 3-4 times the proliferative phase value respectively after two to three years, and then gradually declined in the next three decades to values that were 40-50% of these maximal levels. Testosterone concentrations remained mostly in the normal range for premenopausal women but were depressed to 60% of these levels two to five years after the menopause, and the mean androstenedione levels showed a significant increase in the same group of women. The concentrations of both oestrone and oestradiol remained consistently low for 10 years after the menopause, but oestradiol concentrations inexplicably increased in the last two decades, with levels at the lower end of normal range for reproductive women in six patients.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (900K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Coble YD, Jr, Kohler PO, Cargille CM, Ross GT. Production rates and metabolic clearance rates of human follicle-stimulating hormone in premenopausal and postmenopausal women. J Clin Invest. 1969 Feb;48(2):359–363.[PMC free article] [PubMed] [Google Scholar]
  • Longcope C. Metabolic clearance and blood production rates of estrogens in postmenopausal women. Am J Obstet Gynecol. 1971 Nov;111(6):778–781. [PubMed] [Google Scholar]
  • Judd HL, Judd GE, Lucas WE, Yen SS. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab. 1974 Dec;39(6):1020–1024. [PubMed] [Google Scholar]
  • Vermeulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab. 1976 Feb;42(2):247–253. [PubMed] [Google Scholar]
  • Odell WD, Swerdloff RS. Progestogen-induced luteinizing and follicle-stimulating hormone surge in postmenopausal women: a simulated ovulatory peak. Proc Natl Acad Sci U S A. 1968 Oct;61(2):529–536.[PMC free article] [PubMed] [Google Scholar]
  • Abe K, Nagata N, Saito S, Tanaka K, Kaneko T. Effects of synthetic luteinizing hormone-releasing hormone on plasma levels of luteinizing hormone and follicle-stimulating hormone in man. Endocrinol Jpn. 1972 Feb;19(1):77–84. [PubMed] [Google Scholar]
  • Hunter WM, Greenwood FC. A radio-immunoelectrophoretic assay for human growth hormone. Biochem J. 1964 Apr;91(1):43–56.[PMC free article] [PubMed] [Google Scholar]
  • Hennam JF, Collins WP. A cost reductive method for the radioimmunoassay of plasma androstenedione. A comparison of antisera and the effects of chromatography. Acta Endocrinol (Copenh) 1974 Jul;76(3):597–607. [PubMed] [Google Scholar]
  • Tyler JP, Hennam JF, Newton JR, Collins WP. Radioimmunoassay of plasma testosterone without chromatography: a comparison of four antisera, and the evaluation of a novel approach to liquid scintillation counting. Steroids. 1973 Dec;22(6):871–889. [PubMed] [Google Scholar]
  • Collins WP, Koullapis EN, Sommerville IF. The effect of chlormadinone acetate on progesterone secretion and metabolism. Acta Endocrinol (Copenh) 1971 Oct;68(2):271–284. [PubMed] [Google Scholar]
  • Barnard GJ, Hennam JF, Collins WP. Further studies on radioimmunoassay systems for plasma oestradiol. J Steroid Biochem. 1975 Feb;6(2):107–116. [PubMed] [Google Scholar]
  • Judd HL, Lucas WE, Yen SS. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol. 1974 Mar 15;118(6):793–798. [PubMed] [Google Scholar]
  • Horton R, Tait JF. Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone. J Clin Invest. 1966 Mar;45(3):301–313.[PMC free article] [PubMed] [Google Scholar]
  • Barberia JM, Thorneycroft IH. Simultaneous radioimmunoassay of testosterone and dihydrotestosterone. Steroids. 1974 May;23(5):757–766. [PubMed] [Google Scholar]
  • LOBOTSKY J, WYSS HI, SEGRE EJ, LLOYD CW. PLASMA TESTOSTERONE IN THE NORMAL WOMAN. J Clin Endocrinol Metab. 1964 Dec;24:1261–1265. [PubMed] [Google Scholar]
  • Hemsell DL, Grodin JM, Brenner PF, Siiteri PK, MacDonald PC. Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab. 1974 Mar;38(3):476–479. [PubMed] [Google Scholar]
  • Baird D, Horton R, Longcope C, Tait JF. Steroid prehormones. Perspect Biol Med. 1968 Spring;11(3):384–421. [PubMed] [Google Scholar]
  • Longcope C, Williams KI. The metabolism of estrogens in normal women after pulse injections of 3H-estradiol and 3H-estrone. J Clin Endocrinol Metab. 1974 Apr;38(4):602–607. [PubMed] [Google Scholar]
  • Barlow JJ, Emerson K, Jr, Saxena BN. Estradiol production after ovariectomy for carcinoma of the breast. N Engl J Med. 1969 Mar 20;280(12):633–637. [PubMed] [Google Scholar]
  • Studd JW, Chakravarti S, Oram D. Practical problems of the treatment of the climacteric syndrome. Postgrad Med J. 1976;52 (Suppl 6):60–65. [PubMed] [Google Scholar]
Abstract
The endocrinological changes of the climacteric have been defined by studying the concentrations of follicle-stimulating hormone (FSH), luteinising hormone (LH), androstenedione, testosterone, oestrone, and oestradiol in 60 normal postmenopausal women of different menopausal ages. The women were studied in six groups, according to the number of years since their menopause. One year after the menopause androstenedione, oestrone, and oestradiol concentrations were reduced to about 20% of the values recorded during the early proliferative phase of the menstrual cycle. At the same time the mean concentration of FSH had risen by a factor of 13-4 and that of LH by a factor of 3-0. Concentrations of both gonadotrophins reached a peak of 18-4 and 3-4 times the proliferative phase value respectively after two to three years, and then gradually declined in the next three decades to values that were 40-50% of these maximal levels. Testosterone concentrations remained mostly in the normal range for premenopausal women but were depressed to 60% of these levels two to five years after the menopause, and the mean androstenedione levels showed a significant increase in the same group of women. The concentrations of both oestrone and oestradiol remained consistently low for 10 years after the menopause, but oestradiol concentrations inexplicably increased in the last two decades, with levels at the lower end of normal range for reproductive women in six patients.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.